Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673222 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-EPH Receptor A2 (EPHA2) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human EPHA2, identical to the related rat and mouse sequences.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Effect of ephrin-A1/EphA2 on invasion of trophoblastic cells.
Mycobacterium tuberculosis interferes with the response to infection by inducing the host EphA2 receptor.
The Eck receptor tyrosine kinase is implicated in pattern formation during gastrulation, hindbrain segmentation and limb development.
Yang Y, Min J
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2011 Dec;31(6):824-7
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2011 Dec;31(6):824-7
Mycobacterium tuberculosis interferes with the response to infection by inducing the host EphA2 receptor.
Khounlotham M, Subbian S, Smith R 3rd, Cirillo SL, Cirillo JD
The Journal of infectious diseases 2009 Jun 15;199(12):1797-806
The Journal of infectious diseases 2009 Jun 15;199(12):1797-806
The Eck receptor tyrosine kinase is implicated in pattern formation during gastrulation, hindbrain segmentation and limb development.
Ganju P, Shigemoto K, Brennan J, Entwistle A, Reith AD
Oncogene 1994 Jun;9(6):1613-24
Oncogene 1994 Jun;9(6):1613-24
No comments: Submit comment
No validations: Submit validation data